Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2 S-RWD).
Moreno-Pérez O, Reyes-Garcia R, Modrego-Pardo I, Doulatram-Gamgaram VK, Cases CC, Guillen-Morote C, Mendoza NA, Tejera-Pérez C, Cárdenas-Salas J, Martínez-Fuster S, Lardiés-Sánchez B, Márquez-Pardo R, Pinés P, Fernández-García JC; SEEN Diabetes Area.
Moreno-Pérez O, et al.
Diabetes Obes Metab. 2024 Apr;26(4):1519-1523. doi: 10.1111/dom.15431. Epub 2023 Dec 27.
Diabetes Obes Metab. 2024.
PMID: 38151966
No abstract available.